Groowe Groowe / Newsroom / SLNO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SLNO News

Soleno Therapeutics, Inc. Common Stock

Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman

globenewswire.com
SLNO

SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud Investigation

accessnewswire.com
SLNO

SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.

businesswire.com
SLNO

Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results

globenewswire.com
SLNO

SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP

globenewswire.com
SLNO

Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

globenewswire.com
SLNO RCEL COTY

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

prnewswire.com
SLNO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

accessnewswire.com
SLNO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

globenewswire.com
SLNO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

accessnewswire.com
SLNO